" class="no-js "lang="en-US"> PhenoVista Biosciences - Medtech Alert
Saturday, March 22, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
PhenoVista Biosciences | Pharmtech Focus

PhenoVista Biosciences

About PhenoVista Biosciences

PhenoVista Biosciences

Service provider of high content imaging-based phenotypic assay development and screening services.

Assay areas include:
3D Assay Development for a variety of cell types and models
Human iPS-derived Neuronal Health (Outgrowth, Autophagy, Synapse formation, Mitochondrial function)
Mitochondrial structure and function
Uptake and Subcellular localization of Therapeutic Antibodies
Differentiation of human primary cells
Metabolic function and disorders
Immuno-oncology screens

For more information contact our scientists today at contact@phenovista.com
Follow us on twitter http://twitter.com/phenovista

Related Story

Drug Development

FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process

January 7 2022

FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem […]